Resection of ciliary body tumours wins EURETINA Video Awards

The intricacies of vitreoretinal surgery in all its glorious complexity was showcased in the 2014
EURETINA Video Awards, with the very high standard of entries this year praised by Francesco
Bandello, president of EURETINA.
First prize went to Maria Isabel Relimpio Lopez, of Spain for her video entitled “Partial Lamellar
Sclerouvectomy of two ciliary body tumours: Two surgical techniques.” Joint second prize awards
went to Peykan Turkcuoglu from Turkey for “Suprachoroidal haemorrhage during pars plana
vitrectomy in a previously vitrectomised eye” and Shokufeh Tavassoli from the UK for “Top ten
intravitreal injection tips”. Third prize was given to Avnindra Gupta from India for “Mystery Unfolds”,
which explored surgical techniques for dealing with macular folds.
Dr Lopez’s prize-winning entry gave an elegant example of partial lamellar sclerouvectomy to deal
with the rare incidence of ciliary body tumours in two patients. This surgical procedure is designed to
remove the tumour and leave intact the outer sclera and sensory retina.
In the video, Dr Lopez noted that malignant melanoma is the most common primary tumour in adults,
with management and surgical strategy depending on the size and extent of the tumour.
In the first case highlighted in the video, the surgeon used trans-illumination to mark the borders of
the tumour before performing a series of sclerotomies away from the tumour site. Since the tumour in
this patient did not affect the sclera, a partial-thickness scleral hinge was made. Cataract surgery was
then performed without IOL implantation to avoid complications during the resection. The patient
was anaesthetised using hypotensive anaesthesia, in which diastolic pressure was kept between 2
mmHg to 4 mmHg to minimise bleeding. The tumour was dissected using scissors, and diathermy was
used to coagulate the tissue.
Technically challenging
After the resection was complete, a complete vitrectomy was performed with additional prophylactic
endolaser applied to the fundus periphery. Any remaining tumour cells were destroyed using
brachytherapy at the end of the surgery. The intraocular lens was injected three months later and
improved the patient’s visual acuity to 0.3. Although technically challenging, the video demonstrated
that partial lamellar sclerouvectomy can be effective in removing some malignant ciliary body
tumours and maintaining good visual outcomes in such rare cases.
Latest Articles
Simulators Benefit Surgeons and Patients
Helping young surgeons build confidence and expertise.
Making Female Leadership More than a Moment
A remarkable global confluence of women in key positions.
ESCRS Talks Technology at AAO
Europe adopts technological advances, US still waiting for lenses and lasers.
Sorting Out Simultaneous Vision IOLs
The ESCRS Eye Journal Club discuss a new landmark paper on IOL classification and the need for harmonisation of terminology for presbyopic IOLs.
Big Advantages to Small-Aperture IOLs
Small-aperture IOLs offer superior image quality with increased range of focus.
Prioritising Self-Care
Benefits of maintaining physical, emotional, and mental health extend beyond the personal sphere.
Valuing Clinical Trial Design
How inclusivity and diversity can enhance scientific accuracy in research.
Knowing Iris Repair: Using Iridodiathermy in Iris Surgery
Prepare for decentred pupils and uneven irides in multiple situations.
Neuroprotectant Treatment for MacTel Type 2
Intravitreal implant releasing ciliary neurotrophic factor found safe and effective in pivotal trials.